NASDAQ:BLRX

BioLineRx SEC Filings & 10K Form

$2.67
-0.06 (-2.20 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.62
Now: $2.67
$2.79
50-Day Range
$2.73
MA: $2.95
$3.50
52-Week Range
$1.40
Now: $2.67
$4.23
Volume581,346 shs
Average Volume1.78 million shs
Market Capitalization$113.77 million
P/E RatioN/A
Dividend YieldN/A
Beta2.08

SEC Filings

BioLineRx (NASDAQ:BLRX) SEC Filings

DateFilerForm TypeView
02/24/2021
11:15 PM
BioLineRx (Filer)
Form EFFECT
02/23/2021
8:12 AM
BioLineRx (Filer)
Form POS AM
02/23/2021
6:02 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2021
6:00 AM
BioLineRx (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/12/2021
8:40 PM
Altium Capital Management LP (Filed by)
BioLineRx (Subject)
Form SC 13G/A
01/29/2021
5:19 AM
BioLineRx (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G/A
01/22/2021
3:21 PM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2021
3:32 PM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/19/2021
8:46 PM
BioLineRx (Subject)
Form FWP
01/19/2021
4:01 PM
BioLineRx (Subject)
Form FWP
01/19/2021
4:00 PM
BioLineRx (Filer)
Form 424B5
01/11/2021
11:15 PM
BioLineRx (Filer)
Form EFFECT
01/06/2021
11:19 AM
BioLineRx (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/31/2020
3:37 PM
BioLineRx (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/31/2020
3:31 PM
BioLineRx (Filer)
Form 424B5
12/16/2020
7:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/16/2020
5:02 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/23/2020
6:08 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2020
6:09 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2020
3:31 PM
BioLineRx (Filer)
Form 424B5
11/03/2020
3:39 PM
BioLineRx (Subject)
BioLineRx (Subject)
Form SC 13G/A
10/30/2020
6:09 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2020
7:45 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2020
3:33 PM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2020
3:30 PM
BioLineRx (Filer)
Form 424B5
09/24/2020
3:30 PM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2020
3:34 PM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2020
6:08 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/12/2020
11:15 PM
BioLineRx (Filer)
Form EFFECT
08/06/2020
6:47 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/05/2020
11:15 PM
BioLineRx (Filer)
Form EFFECT
06/26/2020
3:30 PM
BioLineRx (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
06/10/2020
7:02 AM
BioLineRx (Filer)
Form D
Notice of Exempt Offering of Securities 
06/10/2020
7:00 AM
BioLineRx (Filer)
Form D
Notice of Exempt Offering of Securities 
06/03/2020
7:33 AM
BioLineRx (Filer)
Form 424B5
06/03/2020
7:30 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2020
7:05 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2020
11:00 AM
BioLineRx (Filer)
Form 424B5
05/28/2020
10:56 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/27/2020
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2020
1:54 PM
BioLineRx (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
05/26/2020
7:45 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2020
7:10 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2020
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2020
6:07 AM
BioLineRx (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/12/2020
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2020
9:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2020
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2020
7:50 AM
BioLineRx (Filer)
Form CT ORDER
01/30/2020
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2020
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2020
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2019
3:19 PM
BioLineRx (Filer)
Form CT ORDER
12/13/2019
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2019
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2019
5:21 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2019
8:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2019
7:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2019
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2019
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/06/2019
6:11 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2019
6:00 AM
BioLineRx (Filer)
Form 20-F/A
07/02/2019
9:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2019
6:00 AM
BioLineRx (Filer)
Form 20-F/A
05/28/2019
6:04 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2019
11:26 AM
BioLineRx (Filer)
Form CT ORDER
05/14/2019
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2019
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2019
6:08 AM
BioLineRx (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/28/2019
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2019
6:01 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2019
12:14 PM
BioLineRx (Filer)
Form CT ORDER
03/01/2019
4:12 PM
BioLineRx (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13D/A
02/13/2019
11:15 PM
BioLineRx (Filer)
Form EFFECT
02/08/2019
3:46 PM
BioLineRx (Subject)
Senvest Management, LLC (Filed by)
Form SC 13G
02/08/2019
3:15 PM
BioLineRx (Subject)
Senvest Management, LLC (Filed by)
Form SC 13G/A
02/07/2019
11:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2019
4:12 PM
BioLineRx (Filer)
Form 424B5
02/05/2019
8:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2019
4:52 PM
BioLineRx (Filer)
Form 424B5
02/04/2019
3:30 PM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2019
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2018
3:11 PM
BioLineRx (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/11/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/19/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/18/2018
1:56 PM
BioLineRx (Filer)
Form CT ORDER
10/11/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2018
5:03 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2018
6:01 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2018
6:00 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/17/2018
8:12 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/17/2018
7:57 AM
BioLineRx (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.